Measurement of Type B natriuretic peptide in heparin and K2 EDTA plasma

Clinical Biochemistry

Volumn 43, Issue 4-5, 2010, Pages 483-484

  Daves, Massimo ^a   Pusceddu, Irene ^a   Cemin, Roberto ^b  

^a CENTRAL HOSPITAL OF BOLZANO   (Italy)

^b San Maurizio Regional Hospital   (Italy)

Author keywords

Anticoagulant; Collection tubes; Hearth failure; Natriuretic peptides; Type B natriuretic peptide

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; EDETIC ACID; HEPARIN; LITHIUM;

AGED; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL EVALUATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EXPERIMENTAL STUDY; HUMAN; LABORATORY TEST; MEASUREMENT; PEPTIDE ANALYSIS; PRIORITY JOURNAL; TUBE; VENOUS BLOOD;

AGED; ANTICOAGULANTS; BLOOD SPECIMEN COLLECTION; EDETIC ACID; HEPARIN; HUMANS; NATRIURETIC PEPTIDE, BRAIN;

EID: 76749161354     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.11.009     Document Type: Article

References (12)

1. Clerico A. The increasing impact of laboratory medicine on clinical cardiology. Clin. Chem. Lab. Med. 41 (2003) 871-873
2. De Bold A.J. Atrial natriuretic factor: a hormone produced by the heart. Science 230 (1985) 767-770
3. Cowie M., and Mendez G. BNP and congestive hearth failure. Prog. Cardiovasc. Dis. 44 (2002) 293-321
4. Clerico A., and Emdin M. Diagnostic accuracy and prognostic relevance of the measurement of the cardiac natriuretic peptides: a review. Clin. Chem. 50 (2004) 33-50
5. Zhang Q., Moalem J., Tse J., Scholz P.M., and Weiss H.R. Effect of natriuretic peptides on ventricular myocytes contraction. Eur. J. Pharmacol. 10 (2005) 209-215
6. Swedberg K., Cleland J., Darghie H., et al. Task Force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). Eur. Heart J. 26 (2005) 1115-1140
7. Sanz M.P., Borque L., Rus A., Vicente B., Ramirez Y., and Lasa L. Comparison of BNP and NT-proBNP assay in the approach to the emergency diagnosis of acute dyspnea. J. Clin. Lab. Anal. 20 (2006) 227-232
8. Burke M.A., and Cotts W.G. Interpretation of B-type natriuretic peptide in cardiac disease and other comorbid conditions. Heart Fail. Rev. 12 (2007) 23-36
9. Dupuy A.M., Terrier N., Dubois M., Boularan A.M., and Cristol J.P. Heparin plasma sampling as an alternative to EDTA for BNP determination on the Access-Beckman Coulter-effect of storage at -20 degrees C. Clin. Lab. 52 (2006) 393-397
10. Lippi G., Fortunato A., Salvagno G.L., Montagnana M., Soffiati G., and Guidi G.C. Influence of sample matrix and storage on BNP measurement on the Bayer Advia Centaur. J. Clin. Lab. Anal. 21 (2007) 293-297
11. Wu A.H., Packer M., Smith A., et al. Analytical and clinical evaluation of the Bayer ADVIA Centaur automated B-Type natriuretic peptide assay in patient with hearth failure: a multisite study. Clin. Chem. 50 (2004) 867-873
12. Apple F.S., Panteghini M., Ravkilde J., et al. Quality specifications for B-Type natriuretic peptide assay. Clin. Chem. 51 (2005) 486-493